[Federal Register Volume 78, Number 96 (Friday, May 17, 2013)]
[Notices]
[Pages 29143-29144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11777]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the 
following meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: June 07, 2013, 10:00 a.m. to 4:00 p.m. EDT.
    Place: Audio Conference Call and Adobe Connect Pro.
    The ACCV will meet on Friday, June 07 from 10:00 a.m. to 4:00 p.m. 
(EDT). The public can join the meeting by:
    1. (Audio Portion) Calling the conference phone number 800-369-3104 
and providing the following information:
    Leaders Name: Dr. Vito Caserta
    Password: ACCV
    2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by 
following URL: http://www.adobe.com/go/connectpro_overview.
    Call (301) 443-6634 or send an email to [email protected] if you are 
having trouble connecting to the meeting site.
    Agenda: The agenda items for the June meeting will include, but are 
not limited to: updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice (DOJ), National Vaccine 
Program Office (NVPO), Immunization Safety Office (Centers for Disease 
Control and Prevention), National Institute of Allergy and Infectious 
Diseases (National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). A draft agenda 
and additional meeting materials will be posted on the ACCV Web site 
(http://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the 
meeting. Agenda items are subject to change as priorities dictate.
    Public Comment: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, MD 20857 or email: [email protected]. 
Requests should contain the name, address, telephone number, email 
address, and any business or professional affiliation of the person 
desiring to make an oral presentation. Groups having similar interests 
are requested to combine their comments and present them through a 
single representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. DVIC will notify each 
presenter by email, mail, or telephone of their assigned presentation 
time. Persons who do not file an advance request for a presentation, 
but desire to make an oral statement, may announce it at the time of 
the public comment period. Public participation and ability to comment 
will be limited to space and time as it permits.

[[Page 29144]]

    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 
11C-26, 5600 Fishers Lane, Rockville, MD 20857; Telephone (301) 443-
6593 or email: [email protected].

    Dated: May 13, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-11777 Filed 5-16-13; 8:45 am]
BILLING CODE 4165-15-P